 Adaptive Biotechnologies Corporation NASDAQ:ADPT Q2 2022 Results Conference Call August 3, 2022 4:30 PM ET Company Participants Karina Calzadilla - Head, IR Chad Robins - Co-Founder, CEO Tycho Peterson - CFO Nitin Sood - CCO, MRD Sharon Benzeno - Head, Immune Medicine Conference Call Participants Brian Weinstein - William Blair Daniel Brennan - Cowen Company David Westenberg - Piper Sandler Derik De Bruin - Bank of America Elizabeth Webster - Goldman Sachs Mark Massaro - BTIG Yuko Oku - Morgan Stanley Julia Qin - JP Morgan Operator Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Second Quarter 2022 Earnings Conference Call. 